









Markets
/
Stocks
/
nasdaq-bbot
/

BridgeBio Oncology Therapeutics Ord Shs

BBOT

12.180USD

-0.340-2.72%

Close 12/22, 16:00（ET）Quotes delayed by 15 min

286.34MMarket Cap

60.33P/E TTM



BridgeBio Oncology Therapeutics Ord Shs

12.180

-0.340-2.72%

Overview Company Financials Analysis

Overview

Company

Financials

Analysis

You can check out the annual or quarterly balance sheets of BridgeBio Oncology Therapeutics Ord Shs here to evaluate the financial health, analyze fundamentals, and calculate key ratios for liquidity, leverage, and return on equity.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2025Q2

Total equity

Cash, cash equivalents and short-term investments

--664.23K

- Cash and cash equivalents

--664.23K

Prepaid expenses

--212.55K

Total current assets

--876.78K

Non-current assets

Total non-current assets

--196.51M

Total assets

--197.39M

Liabilities

Current liabilities

Total current liabilities

--2.63M

Non-current liabilities

Long-term debt and lease liabilities

--0.00

Deferred liabilities

--5.52M

Other non-current liabilities

--5.52M

Total non-current liabilities

--5.52M

Total liabilities

--8.15M

Shareholders' equity

Common equity

--196.51M

Retained earnings

---7.27M

Total equity

--189.24M

Currency unit

USD

Audit opinions

FAQs

What is the balance sheet?



It is a financial report that summarises the assets, liabilities, and shareholders’ equity of a company at a specific point in time.

KeyAI

